Statins in the Treatment of Hepatitis C

被引：8
作者：
Vere, Cristin Constantin [1 ]
Streba, Costin Teodor [1 ]
Streba, Liliana [1 ]
Rogoveanu, Ion [1 ]
机构：
[1] Univ Med & Pharm Craiova, Internal Med & Gastroenterol Dept, Craiova 200349, Dolj, Romania
来源：
HEPATITIS MONTHLY | 2012年 / 12卷 / 06期
关键词：
Hepatitis C; Antiviral; Therapy; VIRUS-RNA REPLICATION; GENOTYPE; INFECTION; LOW-DENSITY; HCV; GERANYLGERANYLATION; HEPATOTOXICITY; PEGINTERFERON; INTERFERON; BOCEPREVIR; RIBAVIRIN;
D O I：
10.5812/hepatmon.5998
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：369 / 371
页数：3
相关论文
共 20 条
  • [1] Characterization of low- and very-low-density hepatitis C virus RNA-containing particles
    André, P
    Komurian-Pradel, F
    Deforges, S
    Perret, M
    Berland, JL
    Sodoyer, M
    Pol, S
    Bréchot, C
    Paranhos-Baccalà, G
    Lotteau, V
    [J]. JOURNAL OF VIROLOGY, 2002, 76 (14) : 6919 - 6928
  • [2] Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection
    Bacon, Bruce R.
    Gordon, Stuart C.
    Lawitz, Eric
    Marcellin, Patrick
    Vierling, John M.
    Zeuzem, Stefan
    Poordad, Fred
    Goodman, Zachary D.
    Sings, Heather L.
    Poordad, Fred
    Goodman, Zachary D.
    Sings, Heather L.
    Boparai, Navdeep
    Burroughs, Margaret
    Brass, Clifford A.
    Albrecht, Janice K.
    Esteban, Rafael
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (13) : 1207 - 1217
  • [3] Fluvastatin inhibits hepatitis C replication in humans
    Bader, Ted
    Fazili, Javid
    Madhoun, Mohammed
    Aston, Christopher
    Hughes, Diane
    Rizvi, Syed
    Seres, Ken
    Hasan, Muhammad
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 (06) : 1383 - 1389
  • [4] New treatments for chronic hepatitis C virus infection
    Corouge, M.
    Pol, S.
    [J]. MEDECINE ET MALADIES INFECTIEUSES, 2011, 41 (11): : 579 - 587
  • [5] Statins Potentiate the In Vitro Anti-Hepatitis C Virus Activity of Selective Hepatitis C Virus Inhibitors and Delay or Prevent Resistance Development
    Delang, Leen
    Paeshuyse, Jan
    Vliegen, Inge
    Leyssen, Pieter
    Obeid, Susan
    Durantel, David
    Zoulim, Fabien
    de Beeck, Anne Op
    Neyts, Johan
    [J]. HEPATOLOGY, 2009, 50 (01) : 6 - 16
  • [6] Do statins reduce hepatitis C RNA titers during routine clinical use?
    Forde, Kimberly A.
    Law, Connie
    O'Flynn, Rose
    Kaplan, David E.
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2009, 15 (40) : 5020 - 5027
  • [7] Host factors and failure of interferon-α treatment in hepatitis C virus
    Gao, B
    Hong, F
    Radaeva, S
    [J]. HEPATOLOGY, 2004, 39 (04) : 880 - 890
  • [8] Experience with statin use in patients with chronic hepatitis C in infection
    Gibson, K
    Rindone, JP
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2005, 96 (09) : 1278 - 1279
  • [9] Serum Cholesterol and Statin Use Predict Virological Response to Peginterferon and Ribavirin Therapy
    Harrison, Stephen A.
    Rossaro, Lorenzo
    Hu, Ke-Qin
    Patel, Keyur
    Tillmann, Hans
    Dhaliwal, Sandeep
    Torres, Dawn M.
    Koury, Kenneth
    Goteti, Venkata S.
    Noviello, Stephanie
    Brass, Clifford A.
    Albrecht, Janice K.
    McHutchison, John G.
    Sulkowski, Mark S.
    [J]. HEPATOLOGY, 2010, 52 (03) : 864 - 874
  • [10] Different anti-HCV profiles of statins and their potential for combination therapy with interferon
    Ikeda, Masanori
    Abe, Ken-ichi
    Yamada, Masashi
    Dansako, Hiromichi
    Naka, Kazuhito
    Kato, Nobuyuki
    [J]. HEPATOLOGY, 2006, 44 (01) : 117 - 125
12